The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Tenet Healthcare's revenues will increase 2.9% and EPS will drop -42.6%.
The average estimate for revenue is $2.62 billion. On the bottom line, the average EPS estimate is $0.31.
Last quarter, Tenet Healthcare reported revenue of $2.53 billion. GAAP reported sales were 7.3% higher than the prior-year quarter's $2.17 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.60. GAAP EPS were $0.45 for Q4 compared to -$0.70 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 36.6%, 80 basis points better than the prior-year quarter. Operating margin was 9.3%, 30 basis points better than the prior-year quarter. Net margin was 2.1%, 530 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $10.44 billion. The average EPS estimate is $2.71.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 367 members out of 435 rating the stock outperform, and 68 members rating it underperform. Among 88 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 78 give Tenet Healthcare a green thumbs-up, and 10 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Tenet Healthcare is outperform, with an average price target of $29.50.
Is Tenet Healthcare the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Tenet Healthcare to My Watchlist.